The good Dr T on the front foot again (apologies if its already been posted):
PharmAust CEO Dr Michael Thurn spoke with Ashtyn Hiron from Sto_khe_d about the Phase 1 clinical trial of the drug monepantel (MPL) in patients with motor neurone disease (MND/ALS).
https://lnkd.in/gDdPB882
Ann: Options Offer to Existing Listed Option Holders, page-51
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.005(2.44%) |
Mkt cap ! $83.14M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 22.0¢ | 21.0¢ | $262.8K | 1.225M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25394 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 44560 | 3 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |